Literature DB >> 32241897

Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements).

Philip Wai Yan Chiu1, Siew C Ng2, Haruhiro Inoue3, D Nageshwar Reddy4, Enqiang Ling Hu5, Joo Young Cho6, Lawrence Ky Ho7, David G Hewett8,9, Han-Mo Chiu10, Rungsun Rerknimitr11, Hsiu-Po Wang12, Shiaw Hooi Ho13, Dong Wan Seo14, Khean-Lee Goh15, Hisao Tajiri16,17, Seigo Kitano18, Francis K L Chan19.   

Abstract

Coronavirus-19 (COVID-19) caused by SARS-CoV-2 has become a global pandemic. Risk of transmission may occur during endoscopy and the goal is to prevent infection among healthcare professionals while providing essential services to patients. Asia was the first continent to have a COVID-19 outbreak, and this position statement of the Asian Pacific Society for Digestive Endoscopy shares our successful experience in maintaining safe and high-quality endoscopy practice at a time when resources are limited. Sixteen experts from key societies of digestive endoscopy in Asia were invited to develop position statements, including patient triage and risk assessment before endoscopy, resource prioritisation and allocation, regular monitoring of personal protective equipment, infection control measures, protective device training and implementation of a strategy for stepwise resumption of endoscopy services after control of the COVID-19 outbreak. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  clinical decision making; endoscopy

Mesh:

Year:  2020        PMID: 32241897      PMCID: PMC7211066          DOI: 10.1136/gutjnl-2020-321185

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


Introduction

In the past 3 months, a new coronavirus of SARS-CoV-2, leading to coronavirus disease 2019 (COVID-19), has been rapidly disseminated throughout Asia.1 The World Health Organization (WHO) declared COVID-19 as pandemic on 11 March 2020, and by 24 March 2020 the number of confirmed COVID-19 cases had increased to more than 372 000 globally.2 A cohort study on 1099 patients with COVID-19 from Wuhan showed that typical clinical symptoms included cough and sputum, sore throat, fever, fatigue, and shortness of breath.3 More than 40% of patients had contact history and 56.2% had no raised temperature. Gastrointestinal symptoms are not uncommon and 5% of patients had nausea or vomiting and 3.8–10.1% had diarrhoea.4 The overall mortality was 1.4%, and for those with severe disease the mortality was 22.4%.3 5 6 Although there are no data on whether endoscopy is an aerosol-generating procedure, positive insufflation during endoscopic procedures could pose a risk of generating aerosol and increase the risk of SARS-CoV-2 transmission. Healthcare providers of endoscopy therefore are facing tremendous risk during the pandemic of COVID-19 as the spread is mainly through direct contact or aerosol droplets, and endoscopy procedures require a short physical distance between patients and personnel. A study performed during the SARS outbreak in 2003 showed that droplets from infected patients could reach people located two metres or more from the source.7 In addition, experience from the SARS epidemics demonstrated the presence of coronavirus in stool samples and intestinal biopsy samples.8 Recently, it has been confirmed that COVID-19 can be found in the oral cavity and faecal samples of infected individuals.9–12 To date, joint new guidance on the practice of endoscopy has been posted by the American College of Gastroenterology and the British Society of Gastroenterology.13 14 Contrary to western countries, Asia has already accumulated substantial experience in combating the COVID-19 outbreak; some regions have shown their ability to prevent outbreaks and maintain a high-quality endoscopy service without subjecting patients and staff to undue health hazards. The Asian Pacific Society for Digestive Endoscopy (APSDE) gathered experts to develop a position paper on the practice of endoscopy during the COVID-9 pandemic. The current position statements represent expert opinion and also our experience in combating this outbreak at a time when the supply of personal protective equipment is limited. Our objective is to provide recommendations for endoscopy centres on management and preventive measures during the COVID-19 pandemic. APSDE emphasises that risk management protocols should be developed according to healthcare priorities and available resources of individual centres. These statements should be considered as a framework of good clinical practice rather than a medicolegal reference.

Methods

The lead authors (PWYC, SCN and FKLC) were appointed by APSDE to review the literature and to invite experts. and developed the position statement. The members of the writing committee were selected based on the following criteria: (1) international experts of digestive endoscopy in Asia; (2) practical experience in restructuring or monitoring endoscopy service for the COVID-19 outbreak; (3) experience in hospital administration or crisis management. Strategies to triage and assess risk of patients with suspected or confirmed COVID-19 before endoscopy are essential. Deferment of elective endoscopies should be considered until further notice during the COVID-19 outbreak. Urgent endoscopies should be performed by strategically assigned staff to minimise concomitant exposure. Resource reallocation for staff and medical equipment is recommended to prepare for a surge in healthcare demand. Regular monitoring of supply and use of personal protective equipment (PPE) is necessary to adjust endoscopy service and uphold morale of staff. Healthcare workers should practise standard infection control for endoscopy. Healthcare workers should receive adequate training on gowning and removal of PPE. Extra precaution is recommended during colonoscopies as prolonged faecal shedding of SARS-CoV-2 can occur. Endoscopies should be performed in a negative pressure room when available with strict isolation precautions in suspected or confirmed cases of COVID-19. Disinfection policy for endoscopy rooms and reprocessing of instruments should be enhanced. Stepwise resumption of elective endoscopy services should be guided by control of COVID-19 in the local community, availability of manpower and equipment supply.

Statements

Statement 1. Strategies to triage and assess risk of patients with suspected or confirmed COVID-19 before endoscopy are essential

During the COVID-19 pandemic, patients should be screened, triaged and risk stratified before the arrangement of endoscopy (figure 1). WHO defined a confirmed case of COVID-19 as a person with laboratory confirmation of COVID-19 infection, irrespective of clinical signs and symptoms.2 A probable case is defined as a suspected case for whom testing for COVID-19 is inconclusive.2 A suspected case is defined based on the following three criteria: (1) patients with acute respiratory illness with no other aetiology and a history of travel to, or resident in, countries reporting local transmission of COVID-19 during 14 days before symptom onset; (2) patients with acute respiratory illness who have been in contact with a confirmed or probable case of COVID-19 in the past 14 days before symptom onset and (3) patients with severe acute respiratory infection requiring hospitalisation and with no other cause that fully explains the clinical presentation.2
Figure 1

Flow chart to prescreen and triage patients for endoscopy during COVID-19 outbreak. PPE, personal protective equipment.

Flow chart to prescreen and triage patients for endoscopy during COVID-19 outbreak. PPE, personal protective equipment. Before arrival at endoscopy centres, all patients need to undergo prescreening and the following information should be collected to the best of the ability of each centre: (1) fever of more than 37.5 C (F); (2) travel history (T); (3) occupational exposure (O); (4) contact history (C); (5) clustering (C) (FTOCC).15 The travel history should include all recent travels to countries with a high incidence of COVID-19 within the past 14 days. The occupational exposure should include those working as healthcare providers and research laboratory staff handling specimens of COVID-19. The contact history should trace those who have had recent close contact with patients with COVID-19 in the past 14 days and those who had contacts who had recently travelled to high-risk countries. The clustering represents two or more COVID-19 positive patients with a history of close contact. Any of the positive criteria for FTOCC should be regarded as a clinically suspected case, and COVID-19 testing should be conducted before any endoscopic procedure. For all suspected, probable or confirmed cases, the clinical indication for endoscopy should be reviewed, and only those with emergency or life-threatening conditions should receive endoscopy (see statement 3).

Statement 2. Deferment of elective endoscopies should be considered until further notice during the COVID-19 outbreak

A report from Hong Kong, based on experience with SARS, showed that the risk of infection is 5% for physicians, 4% for nurses and 8% for healthcare assistants.16 The authors emphasised the importance of practising strict isolation, infection control measures and adherence to use of personal protective equipment. Most Asian countries adopted a policy of suppression to reduce the epidemic of COVID-19 through case identification, contact tracing and hospitalisation, and had vigorous strategies for population-wide social distancing.17 According to the prediction model of the Imperial College COVID-19 response team, a suppression policy can significantly reduce mortality and the stress on hospital care capacity.17 However, it will require sustainability until a vaccine is available. We recommend deferring all elective endoscopies during the COVID-19 outbreak until the pandemic is over. This strategy helps to preserve the surge capacity for hospitals to manage a massive number of suspected or confirmed cases of COVID-19.15 16 18 Moreover, this will safeguard the potential transmission of COVID-19 between patients and to healthcare providers, especially at the beginning of the COVID-19 outbreak.16 18 It will also allow time for healthcare providers at the endoscopy centre to receive appropriate education and training on infection control measures. A retrospective case series from Iran reported on four surgical patients who developed severe complications after elective surgery in the first few weeks of COVID-19. All showed either clinical signs or tested positive for COVID-19, and three out of four patients died.19 The endoscopy centre should keep a record of patients with deferred endoscopy appointments and rearrange their appointments according to the situation of the COVID-19 outbreak. Table 1 shows the list of elective procedures that could be deferred until further notice.
Table 1

Classification of endoscopic procedures as urgent, semi-urgent and elective during COVID-19 outbreak

Urgent endoscopySemi-urgent endoscopy (to be discussed on a case by case basis)Elective endoscopy (deferred until further notice)
Acute gastrointestinal BleedingManagement of perforations and leakageBiliary sepsisForeign bodyGastrointestinal obstruction requiring stentingGI access for urgent feedingEndoscopic treatment for gastrointestinal neoplasia (EMR/ESD)Endoscopy for highly suspicious case of cancerSmall bowel enteroscopy for occult GI bleedingERCP for hepatobiliary pancreatic cancersAll routine diagnostic endoscopyAll surveillance and follow-up endoscopy (Barrett’s oesophagus/polyp/IBD/gastric intestinal metaplasia/history of GI cancer)Therapeutic endoscopy for non-cancer diseaseOther ERCP cases–asymptomatic stones; therapy for chronic pancreatitis; metal stent removal/change; ampullectomy follow-upEUS for diagnosis of benign conditionERCP for non-malignant conditionsEndoscopic therapy for benign GI disorders (bariatric, GORD)

EMR, endoscopic mucosal resection; ERCP, endoscopic retrograde cholangiopancreatography; ESD, endoscopic submucosal dissection; EUS, endoscopic ultrasonography; GORD, gastro-oesophageal reflux disease; IBD, inflammatory bowel disease.

Classification of endoscopic procedures as urgent, semi-urgent and elective during COVID-19 outbreak EMR, endoscopic mucosal resection; ERCP, endoscopic retrograde cholangiopancreatography; ESD, endoscopic submucosal dissection; EUS, endoscopic ultrasonography; GORD, gastro-oesophageal reflux disease; IBD, inflammatory bowel disease. For patients who require semi-urgent endoscopic procedures, clinicians should decide case by case on the need and indications, and those indicated should be performed as urgent endoscopic procedures (table 1).

Statement 3. Urgent endoscopies should be performed by strategically assigned staff to minimise concomitant exposure

During the COVID-19 outbreak, recommended indications for urgent endoscopy are limited to acute gastrointestinal bleeding, biliary sepsis, gastrointestinal obstruction requiring stenting or dilatation, management of gastrointestinal perforations and leakage, foreign body retrieval and establishment of access for enteral nutrition (table 1). Where urgent endoscopies are necessary, we recommend keeping the number of staff to a minimum, with preferably one experienced endoscopist and two nurses for each endoscopy room. Ample time should be allowed for infection control measures before and after endoscopy. The same team of endoscopy staff should serve the same room for the whole session.

Statement 4. Resource reallocation for staff and medical equipment is recommended to prepare for a surge in healthcare demand

The hospital system will undergo major stress due to a surge in the demand for the management of suspected and confirmed cases of COVID-19. As a result, endoscopy centres should rationalise and prioritise the allocation of resources, including endoscopists, nurses, healthcare providers and medical equipment.20 All healthcare providers working at the endoscopy centre should receive appropriate education and training on infection control measures, including hand hygiene and use of personal protective equipment (PPE).21 22 The endoscopy centre should arrange designated gown up and gown down areas. The supply of medical equipment, especially PPE, will be limited during the pandemic.

Statement 5. Regular monitoring of supply and use of personal protective equipment (PPE) is necessary to adjust endoscopy service and uphold morale of staff

The use of medical supplies should be carefully planned. Administrators of the endoscopy centre should regularly communicate with the hospital administration about the supply and logistics of medical equipment and PPE. The stock and use of consumables, PPE and other equipment should be monitored daily to allow better planning of service and to avoid inadequate supply of PPE, which may jeopardise safety and morale of staff. Conservation of PPE is critical and only essential personnel should be present during procedures (). Type of endoscopy procedures in relation to the use of PPE (standard or enhanced), manpower and frequency of gown down AGP, aerosol generating procedure; ERCP, endoscopic retrograde cholangiopancreatography; OGD, oesophagogastroduodenoscopy; PPE, personal protective equipment.

Statement 6. Healthcare workers should practise standard infection control for endoscopy

SARS-CoV-2 has been shown to be transmitted indirectly through contaminated surfaces and fomites, and survival of virus on surfaces can last for hours to days.23 Similarly, SARS-CoV-2 survival has been reported in confined public spaces, including restrooms, elevators and door knobs.24 All endoscopists, nurses and healthcare providers should receive training on infection control and appropriate use of PPE during endoscopy.21 22 25 26 Standard hand hygiene procedures before and after each case should be practised. Ethanol (62–71% concentration), 2% glutaraldehyde and 0.1–0.5% sodium hypochlorite are commonly used as disinfectants and can reduce the concentrations of coronavirus within 1 min of exposure time.27 Effective hand hygiene decreases the risk of transmission and was proved to be beneficial during SARS.28 Universal hand washing and the use of alcohol-based hand rubs on entering and leaving endoscopy rooms are highly recommended. We recommend the use of PPE according to risk stratification (table 2). The definition of a suspected, probable and confirmed case is listed by WHO.2 For patients defined as suspected, probable or confirmed COVID-19, enhanced PPE should be practised during endoscopy, including the use of a N95 mask; isolation gown with water resistance; head cover; eye protection and face shield.25 26 29 The procedure should be conducted in negative pressure room when available (see statement 9).
Table 2

Type of endoscopy procedures in relation to the use of PPE (standard or enhanced), manpower and frequency of gown down

ProcedureAGPStandard PPE for non-suspected/test negative casesEnhanced PPE for high risk/confirmed COVID-19Endoscopist manpowerEndoscopy nurses manpowerFrequency of gown down
OGD To be determinedSurgical mask or N95Blue isolation gownGlovesStandard endoscopy roomN95Blue isolation gownGlovesGoggles or face shieldNegative pressure room1 (at specialist level)2Mask: end of each sessionGown: change when contaminatedGloves: after each case
Colonoscopy To be determinedSurgical mask or N95Blue isolation gownGlovesStandard endoscopy roomN95Blue isolation gownGlovesGoggles or face shieldNegative pressure room1 (at specialist level2Mask: end of each sessionGown: change when contaminatedGloves: after each case
ERCP To be determinedSurgical mask or N95Blue isolation gownGlovesStandard endoscopy roomN95Blue isolation gownGlovesGoggles or face shieldNegative pressure room (with enough space and X-ray shielding)1 (at specialist level)2Mask: end of each sessionGown: change when contaminatedGloves: after each case
Bronchoscopy YesN95Blue isolation gownGlovesGoggles or face shieldNegative pressure roomN95Blue isolation gownGlovesGoggles or face shieldNegative pressure room1 (at specialist level)2Mask: end of each sessionGown: change when contaminatedGloves: after each case

AGP, aerosol generating procedure; ERCP, endoscopic retrograde cholangiopancreatography; OGD, oesophagogastroduodenoscopy; PPE, personal protective equipment.

For patients who are FTOCC negative and not suspected to have COVID-19, healthcare providers should perform endoscopy with PPE, including a face mask; isolation gown with water resistance; eye protection. As endoscopy may be an aerosol-generating procedure, endoscopists should be allowed to select the most appropriate PPE for the procedure. Interactions with patients, including informed consent and checking vital signs, should be performed while maintaining some distance, and with rigorous hand washing before and after interactions.

Statement 7. Healthcare workers should receive adequate training on gowning and removal of PPE

Many health workers, including endoscopists, nurses, healthcare workers and anaesthetists, work in endoscopy suites, with different types of procedures being performed daily. There is a certain risk of exposing staff to respiratory, oropharyngeal and faecal secretions. Furthermore, aggressive suctioning and multiple catheter exchange via endoscope working channels may expose staffs to splashes of secretion.30 Microorganisms have been detected on the walls of endoscopy suite and postoperative recovery areas.31 During the SARS epidemic, 21% of people affected were healthcare workers.32 The grouping of many patients and healthcare workers at endoscopy can put them at risk of human to human transmission. For patients with COVID-19 who require endoscopic procedures under general anaesthesia, anaesthesis should be conducted by a designated team while other members of the endoscopy team should stay outside the room. The anaesthetic procedure should be performed with all healthcare providers in full PPE.33 Biopsy samples obtained from the infected person can also be a source of infection as active viral replication was identified during the SARS pandemic in 2003.8 Hence, all specimen from patients with COVID-19 should be handled with extra precaution and with appropriate protective equipment. Training should be provided for all staff for PPE gowning and downing. Figure 2 illustrates the typical PPE used in our unit in Hong Kong.
Figure 2

Recommended PPE for general patient triage and handling suspected COVID-19 cases. AAMI, Association for the Advancement of Medical Instrumentation; PPE, personal protective equipment. Image courtesy of the Hospital Authority of Hong Kong.

Recommended PPE for general patient triage and handling suspected COVID-19 cases. AAMI, Association for the Advancement of Medical Instrumentation; PPE, personal protective equipment. Image courtesy of the Hospital Authority of Hong Kong.

Statement 8. Extra precaution is recommended during colonoscopies as prolonged faecal shedding of SARS-CoV-2 can occur

Although the risk of faecal transmission for SARS-Cov-2 is not clear, it remains plausible as SARS-CoV-2 has been detected in the stool of patients with and without symptoms, and viral shedding occurs.9–12 It may also persist despite negative results in the respiratory tract. This can result in viral transmission via aerosolisation and faecal-oral route of contamination.34 A recent study showed that there is prolonged presence of SARS-Cov-2 viral RNA in faecal samples for up to 47 days after onset of the first symptoms.35 As endoscopes are often affected by gut flora, this could pose a risk to endoscopists, nursing staff and other endoscopy staff and could also be a vector for potential transmission to other patients.36 37 Therefore, it is important for staff performing colonoscopies to aware of this potential risk, and colonoscopy should be considered a high-risk procedure and careful decontamination procedures vigilantly performed (see statement 10).

Statement 9. Endoscopies should be performed in a negative pressure room when available with strict isolation precautions in suspected or confirmed cases of COVID-19

For suspected, probable and confirmed COVID-19 cases, ideally we recommend performance of endoscopy in a negative pressure room. As most endoscopy units may not have a negative pressure room, the procedure can be performed in a venue outside the endoscopy centre, with negative pressure in the operation theatre, for example, or in a room with better ventilation. In the endoscopy centre, it is important to keep all patients at an appropriate distance from each other (two metres is recommended) while considering each facility’s situation and capacity. Care givers or relatives of patients are strictly prohibited from entering the endoscopy department except in special circumstances in which patients require specific assistance.

Statement 10. Disinfection policy for endoscopy rooms and reprocessing of instruments should be enhanced

The standard of disinfection and reprocessing of endoscopy instruments should be practised according to American Society for Gastrointestinal Endoscopy and European Society of Gastrointestinal Endoscopy guidelines.25 26 Each endoscopy department should have a detailed plan for cases of non-COVID-19 and suspected or confirmed COVID-19. Standard room disinfection should be conducted at the end of the session in rooms where non-COVID or low-risk patients had endoscopy. For patients with suspected or confirmed COVID-19 who require emergency endoscopy, the endoscopic procedure should be performed at the end of the session and the room should be cleaned after these procedures with staff using appropriate PPE. The disinfection and reprocessing of the endoscope and instruments used for a patient with COVID-19 will be similar to those used in standard practice.25 26 All disposable devices used for a patient with COVID-19 should not be re-used. If treatment of patients with COVID-19 is performed in negative pressure rooms, a delay of 30 min is recommended before a new patient enters the room. Although no cases of endoscope-related COVID-19 transmission have been reported, this risk exists, especially in view of previous experience with hepatitis B and C viruses. It is likely that current endoscope disinfection techniques are sufficient.

Statement 11. Stepwise resumption of elective endoscopy services should be guided by control of COVID-19 in the local community, availability of manpower and equipment supply

With steady increase in the number of confirmed cases of COVID-19 among different countries and cities worldwide, it is difficult to determine the most appropriate time to resume regular service at endoscopy centres. The Imperial College COVID-19 response team predicted that suppression strategies will need adaptive triggering once rebound occurs.17 It is likely that most countries will adopt a time-bound approach in the resumption of partial or full service depending on the following factors: (1) the number and epidemic curve of confirmed COVID-19 cases; (2) the availability of medical equipment, including appropriate PPE; and (3) the accumulated volume of postponed endoscopy cases. Some non-urgent procedures are of higher priority for resumption and may need to be performed, such as cancer evaluations and evaluation of significant symptoms. We recommend that endoscopy centres resume an elective endoscopy service in a stepwise manner in phases (table 3). For example, in the initial phase the daily volume of endoscopic procedures should be 50% of the normal capacity. The situation may also change with a sudden increase in COVID-19 cases, limitation of PPE and other medical supplies, and fatigue or limitation of healthcare providers. The administrators of endoscopy centres should have close and regular communication with the hospital management team and closely monitor the outbreak for any rapid change in plan to keep a sustainable and effective endoscopy service.
Table 3

Provision of endoscopy service during COVID-19 pandemic

COVID-19 in the communityPPE supplyEndoscopy service
Exponential increase in new cases of COVID-19Critical (reserve <7 days)

Urgent endoscopy only

Semi-urgent endoscopy – withhold

Elective endoscopy – withhold

Rapid increase in new cases of COVID-19Very low (reserve <4 weeks)

Urgent endoscopy only

Semi-urgent endoscopy – to be individualised

Elective endoscopy – withhold

Down trend in new cases of COVID-19Suboptimal (reserve 4–8 weeks)

Urgent endoscopy – full capacity

Semi-urgent endoscopy – full capacity

Elective endoscopy – resumed with 50% capacity

No new cases of COVID-19 diagnosed for at least 2 weeksNormal (12 weeks reserve)

Urgent endoscopy – full capacity

Semi-urgent endoscopy – full capacity

Elective endoscopy – full capacity

PPE, personal protective equipment.

Provision of endoscopy service during COVID-19 pandemic Urgent endoscopy only Semi-urgent endoscopy – withhold Elective endoscopy – withhold Urgent endoscopy only Semi-urgent endoscopy – to be individualised Elective endoscopy – withhold Urgent endoscopy – full capacity Semi-urgent endoscopy – full capacity Elective endoscopy – resumed with 50% capacity Urgent endoscopy – full capacity Semi-urgent endoscopy – full capacity Elective endoscopy – full capacity PPE, personal protective equipment.
  31 in total

1.  From SARS to Avian Influenza Preparedness in Hong Kong.

Authors:  Andrew T Y Wong; Hong Chen; Shao-Haei Liu; Enoch K Hsu; Kristine S Luk; Christopher K C Lai; Regina F Y Chan; Owen T Y Tsang; K W Choi; Y W Kwan; Anna Y H Tong; Vincent C C Cheng; Dominic N C Tsang
Journal:  Clin Infect Dis       Date:  2017-05-15       Impact factor: 9.079

2.  Risk of bacterial exposure to the endoscopist's face during endoscopy.

Authors:  Elyse R Johnston; Nadia Habib-Bein; Jeffrey M Dueker; Barbara Quiroz; Enrico Corsaro; Megan Ambrogio; Michael Kingsley; Georgios I Papachristou; Christianna Kreiss; Asif Khalid
Journal:  Gastrointest Endosc       Date:  2018-11-01       Impact factor: 9.427

3.  A Review of Isolation Gowns in Healthcare: Fabric and Gown Properties.

Authors:  F Selcen Kilinc
Journal:  J Eng Fiber Fabr       Date:  2015-09       Impact factor: 1.573

4.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

Review 5.  Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy.

Authors:  Julia Kovaleva; Frans T M Peters; Henny C van der Mei; John E Degener
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

6.  Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses.

Authors:  Anindya Siddharta; Stephanie Pfaender; Nathalie Jane Vielle; Ronald Dijkman; Martina Friesland; Britta Becker; Jaewon Yang; Michael Engelmann; Daniel Todt; Marc P Windisch; Florian H Brill; Joerg Steinmann; Jochen Steinmann; Stephan Becker; Marco P Alves; Thomas Pietschmann; Markus Eickmann; Volker Thiel; Eike Steinmann
Journal:  J Infect Dis       Date:  2017-03-15       Impact factor: 5.226

Review 7.  Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.

Authors:  G Kampf; D Todt; S Pfaender; E Steinmann
Journal:  J Hosp Infect       Date:  2020-02-06       Impact factor: 3.926

8.  Potential association between COVID-19 mortality and health-care resource availability.

Authors:  Yunpeng Ji; Zhongren Ma; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  Lancet Glob Health       Date:  2020-02-25       Impact factor: 26.763

9.  Coronavirus (COVID-19) outbreak: what the department of endoscopy should know.

Authors:  Alessandro Repici; Roberta Maselli; Matteo Colombo; Roberto Gabbiadini; Marco Spadaccini; Andrea Anderloni; Silvia Carrara; Alessandro Fugazza; Milena Di Leo; Piera Alessia Galtieri; Gaia Pellegatta; Elisa Chiara Ferrara; Elena Azzolini; Michele Lagioia
Journal:  Gastrointest Endosc       Date:  2020-03-14       Impact factor: 9.427

10.  Prolonged presence of SARS-CoV-2 viral RNA in faecal samples.

Authors:  Yongjian Wu; Cheng Guo; Lantian Tang; Zhongsi Hong; Jianhui Zhou; Xin Dong; Huan Yin; Qiang Xiao; Yanping Tang; Xiujuan Qu; Liangjian Kuang; Xiaomin Fang; Nischay Mishra; Jiahai Lu; Hong Shan; Guanmin Jiang; Xi Huang
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-03-20
View more
  125 in total

1.  Impact of COVID-19 Pandemic on Gastroenterology Fellowship Training in Turkey: A Prospective Nationwide Survey Study.

Authors:  Coşkun Özer Demirtaş; Cavansir Vahabov; Fuad Mustafayev; Tevhide Sahin; Erkan Parlak
Journal:  Turk J Gastroenterol       Date:  2021-10       Impact factor: 1.852

2.  Guidance and workflow of endoscopy reopening during COVID-19 pandemic.

Authors:  Nahla Azzam; Nora Alotaibi; Majid Almadi; Abdulrahman Aljebreen
Journal:  Saudi J Gastroenterol       Date:  2020 Sep-Oct       Impact factor: 2.485

3.  Restarting gastrointestinal endoscopy in the deceleration and early recovery phases of COVID-19 pandemic: Guidance from the British Society of Gastroenterology.

Authors:  Colin J Rees; James E East; Kofi Oppong; Andrew Veitch; Mark McAlindon; John Anderson; Bu Hayee; Cathryn Edwards; Alastair McKinlay; Ian Penman
Journal:  Clin Med (Lond)       Date:  2020-06-09       Impact factor: 2.659

4.  Recommendations for Reopening Endoscopy Units in Turkey: A Set-up Plan from a Tertiary Center in Istanbul.

Authors:  Coşkun Özer Demirtas; Çağlayan Keklikkıran; Shahin Mehdiyev; İlkay Ergenç; Yeşim Özen Alahdab; Feyza Gündüz; Yusuf Yılmaz; Özlen Atuğ; Osman Cavit Özdoğan
Journal:  Turk J Gastroenterol       Date:  2021-02       Impact factor: 1.852

Review 5.  Coronavirus Disease-2019 (COVID-19) and the Liver.

Authors:  Anshuman Elhence; Manas Vaishnav; Sagnik Biswas; Ashish Chauhan; Abhinav Anand
Journal:  J Clin Transl Hepatol       Date:  2021-03-22

6.  Real-world evaluation of a computed tomography-first triage strategy for suspected Coronavirus disease 2019 in outpatients in Japan: An observational cohort study.

Authors:  Shigeta Miyake; Takuma Higurashi; Takashi Jono; Taisuke Akimoto; Fumihiro Ogawa; Yasufumi Oi; Katsushi Tanaka; Yu Hara; Nobuaki Kobayashi; Hideaki Kato; Tsuneo Yamashiro; Daisuke Utsunomiya; Atsushi Nakajima; Tetsuya Yamamoto; Shin Maeda; Takeshi Kaneko; Ichiro Takeuchi
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

Review 7.  Endoscopy training in COVID-19: Challenges and hope for a better age.

Authors:  Chieh Sian Koo; Kewin Tien Ho Siah; Calvin Jianyi Koh
Journal:  J Gastroenterol Hepatol       Date:  2021-04-28       Impact factor: 4.369

Review 8.  Gastroenterology and liver disease during COVID-19 and in anticipation of post-COVID-19 era: Current practice and future directions.

Authors:  Katerina G Oikonomou; Panagiotis Papamichalis; Tilemachos Zafeiridis; Maria Xanthoudaki; Evangelia Papapostolou; Asimina Valsamaki; Konstantinos Bouliaris; Michail Papamichalis; Marios Karvouniaris; Panagiotis J Vlachostergios; Apostolia-Lemonia Skoura; Apostolos Komnos
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

Review 9.  The use of pediatric flexible bronchoscopy in the COVID-19 pandemic era.

Authors:  Domenico Paolo La Regina; Raffaella Nenna; Dirk Schramm; Nadine Freitag; Pierre Goussard; Ernst Eber; Fabio Midulla
Journal:  Pediatr Pulmonol       Date:  2021-03-17

10.  Rationale for American Society of Retina Specialists Best Practice Recommendations for Conducting Vitreoretinal Surgery during the COVID-19 Era.

Authors:  Daniel L Chao; Jayanth Sridhar; Ajay E Kuriyan; Theodore Leng; Brad P Barnett; Aaron F Carlin; Charles C Wykoff; Stephen Gayer; Prithvi Mruthyunjaya; Yoshihiro Yonekawa; Amani A Fawzi; Audina M Berrocal; Steven Yeh; Daniel Ting; Yasha Modi; David N Zacks; Nicholas Yannuzzi; Natalie A Afshari; Timothy Murray
Journal:  J Vitreoretin Dis       Date:  2020-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.